Delivery Order SPE2DR25D1053-SPE2DR26FT476
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency awarded a $1,221.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 (12 years and up) syringes in 0.3mL doses, with performance in Conshohocken, Pennsylvania and completion targeted for November 14, 2025. This is a non-set-aside, competitively awarded delivery order placed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $38,958.40 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3ml syringes) with a completion deadline of November 20, 2025. This is a firm fixed-price, non-set-aside competitive award performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued on October 29, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a $25,242.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12 years and up, 0.3ml syringes) with an ultimate completion date of October 15, 2025. This non-set-aside award was issued on September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents one of many...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,175.75 on July 8, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. This firm fixed-price delivery order, which was not set aside for small business, is scheduled for completion by July 9, 2025, with performance at the awardee's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.55 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,262.12 for Comirnaty 2025-26 (12 years and up) in 0.3 mL syringes, with an ultimate completion date of October 16, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor at its Conshohocken, Pennsylvania location. The award represents a continuation of pharmaceutical supply deliveries under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with a ceiling value of $1,893.18 and an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for Comirnaty 2024-25 vaccine (12 years and up, 0.3mL syringes) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action under a larger vehicle, this delivery order falls within AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12 years and up, 0.3mL syringes) with a ceiling value of $2,921.88 and an ultimate completion date of November 17, 2025. This is a firm fixed price delivery order under a non-set-aside competition, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT476Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 (12-year-old and up) syringes at 0.3 mL with a ceiling value of $4,869.80. The order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that supports global pharmaceutical and medical supply requirements for military healthcare systems. AmerisourceBergen serves as a critical federal medical vendor supplying a comprehensive range of pharmaceuticals, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. The company's role as a pharmaceutical prime vendor demonstrates its established capability to meet federal medical procurement standards across competitive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 10/30/25 |